Company Details
aurobindopharma
14,616
309,342
3254
aurobindo.com
0
AUR_4566535
In-progress

AUROBINDO PHARMA LTD Company CyberSecurity Posture
aurobindo.comAurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.
Company Details
aurobindopharma
14,616
309,342
3254
aurobindo.com
0
AUR_4566535
In-progress
Between 750 and 799

APL Global Score (TPRM)XXXX



No incidents recorded for AUROBINDO PHARMA LTD in 2025.
No incidents recorded for AUROBINDO PHARMA LTD in 2025.
No incidents recorded for AUROBINDO PHARMA LTD in 2025.
APL cyber incidents detection timeline including parent company and subsidiaries

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.


A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient,
For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists
We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing t

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently addre

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portf

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (C

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing,

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions i
.png)
The announcement from Microsoft follows a campaign of cyberattacks that Microsoft blamed on state-sponsored hackers in China who targeted...
Daily Business News Summary: Stay informed with the summary of Latest Business News from India and around the world, covering all...
India Business News: Indian stock market indices, BSE Sensex and Nifty50, suffered significant declines on Friday, triggered by US recession...
Bharat Electronics (BEL) added 1.40% to Rs 286.35 after the company has signed a contract with Indian Air Force (IAF) valued at Rs 593.22 crore.
India Business News: Indian pharma companies brace for potential US tariffs that could raise drug prices, disrupt supply chains,...
At meeting held on 06 February 2025.
Shares of Dev Information Technology surged up to 7.76 per cent at Rs 163.80 a piece on the BSE in Monday's intraday trade.
The uptick in Shriram Finance share price came after the company announced that it has fixed January 10, 2025 as the 'Record Date' for...
Aurobindo Pharma has completed the installation of its plant in China and is planning to commission it in the first quarter of next fiscal.

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of AUROBINDO PHARMA LTD is https://www.aurobindo.com/.
According to Rankiteo, AUROBINDO PHARMA LTD’s AI-generated cybersecurity score is 777, reflecting their Fair security posture.
According to Rankiteo, AUROBINDO PHARMA LTD currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, AUROBINDO PHARMA LTD is not certified under SOC 2 Type 1.
According to Rankiteo, AUROBINDO PHARMA LTD does not hold a SOC 2 Type 2 certification.
According to Rankiteo, AUROBINDO PHARMA LTD is not listed as GDPR compliant.
According to Rankiteo, AUROBINDO PHARMA LTD does not currently maintain PCI DSS compliance.
According to Rankiteo, AUROBINDO PHARMA LTD is not compliant with HIPAA regulations.
According to Rankiteo,AUROBINDO PHARMA LTD is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
AUROBINDO PHARMA LTD operates primarily in the Pharmaceutical Manufacturing industry.
AUROBINDO PHARMA LTD employs approximately 14,616 people worldwide.
AUROBINDO PHARMA LTD presently has no subsidiaries across any sectors.
AUROBINDO PHARMA LTD’s official LinkedIn profile has approximately 309,342 followers.
AUROBINDO PHARMA LTD is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
No, AUROBINDO PHARMA LTD does not have a profile on Crunchbase.
Yes, AUROBINDO PHARMA LTD maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/aurobindopharma.
As of December 11, 2025, Rankiteo reports that AUROBINDO PHARMA LTD has not experienced any cybersecurity incidents.
AUROBINDO PHARMA LTD has an estimated 5,413 peer or competitor companies worldwide.
Total Incidents: According to Rankiteo, AUROBINDO PHARMA LTD has faced 0 incidents in the past.
Incident Types: The types of cybersecurity incidents that have occurred include .
.png)
FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.
Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.
Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.
Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.
The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.